Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Journal of the American College of Cardiology|August 21, 2007
All is not well in the world of translational researchEllis F UngerClinical Trials (London, England)|March 30, 2023
Subgroup analyses and pre-specificationEllis F UngerDrug Safety|September 15, 2025
The Development and Use of Office of New Drugs Custom Medical Queries for Safety Analyses of Clinical Trial DataScott Proestel, Vaishali Popat, Ellis F Unger, et al.Circulation|October 14, 2015
Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research PerspectiveAlison Blaus, Rajanikanth Madabushi, Michael Pacanowski, et al.The Journal of Clinical Psychiatry|July 28, 2015
Regulatory and scientific issues in studies to evaluate sexual dysfunction in antidepressant drug trialsNi A Khin, Phillip D Kronstein, Peiling Yang, et al.Journal of the American College of Cardiology|May 5, 2018
Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular DrugsPamela E Scott, Ellis F Unger, Marjorie R Jenkins, et al.The Journal of Clinical Psychiatry|January 7, 2015
The US Food and Drug Administration's perspective on the new antidepressant vortioxetineJing Zhang, Mitchell V Mathis, Jenn W Sellers, et al.JACC. Basic to Translational Science|May 28, 2025
Derisking Phase II Clinical Trials in Heart Failure: A Position Paper from JACC: Basic to Translational Science and the Heart Failure CollaboratoryDouglas L Mann, G Michael Felker, Ellis F Unger, et al.Journal of the American College of Cardiology|February 2, 2018
Improving Heart Failure Therapeutics Development in the United States: The Heart Failure CollaboratoryChristopher M O'Connor, Mitchell A Psotka, Mona Fiuzat, et al.The Journal of Clinical Psychiatry|September 29, 2011
Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressantThomas P Laughren, Jogarao Gobburu, Robert J Temple, et al.Pageof 2